Doyoumoney

	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Operating cash flow +	-51.77	-47.42	-33.45	-20.39	-9.26
Net income
Depreciation, depletion and amortization	0.66	0.50	0.37	0.34	0.15
Stock-based compensation	8.11	7.63	2.89	1.76	0.23
Change in inventory
Other working capital changes	-60.54	-55.56	-36.71	-22.50	-9.63
Cash flow from investing +	-0.02	-2.08	-0.47	-0.73	-0.68
Capital expenditures	-0.02	-2.08	-0.47	-0.73	-0.68
Others incl. marketable securities changes	0.00	0.00	0.00	0.00	0.00
Cash flow from financing +	60.08	135.69	68.13	43.79	31.69
Dividend payout
Common stock repurchases	-0.17	0.00
Net Debt Issuance	60.25	135.69	68.13	43.79	31.69

Change in cash	8.29	86.19	34.21	22.66	21.75

Show Quarterly Cash Flow

	Mar-26	Dec-25	Sep-25	Jun-25	Mar-25	Dec-24	Sep-24	Jun-24	Mar-24	Dec-23	Sep-23	Jun-23	Mar-23	Dec-22
Operating cash flow +	-27.09	-11.52	-9.92	-13.78	-16.56	-13.02	-11.73	-11.69	-10.98	-11.52	-7.77	-6.64	-7.52	-6.02
Net income
Depreciation, depletion and amortization	0.18	0.16	0.16	0.17	0.17	0.17	0.14	0.11	0.10	0.09	0.06	0.11	0.09	0.10
Stock-based compensation	2.82	1.95	2.19	2.01	1.97	1.57	2.00	1.89	2.18	0.61	0.54	1.26	0.48	0.94
Change in inventory
Other working capital changes	-30.10	-13.62	-12.27	-15.95	-18.70	-14.76	-13.86	-13.70	-13.26	-12.22	-8.37	-8.01	-8.09	-7.06
Cash flow from investing +	-0.56				-0.02	-0.51	-1.01	-0.34	-0.22	-0.35	-0.04	-0.05	-0.02	-0.06
Capital expenditures	-0.56	0.00	0.00	0.00	-0.02	-0.51	-1.01	-0.34	-0.22	-0.35	-0.04	-0.05	-0.02	-0.06
Others incl. marketable securities changes	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash flow from financing +	114.94	50.19	0.15	0.61	9.13	0.05	1.32	-0.23	134.56	43.13	0.05	-0.05	25.00	19.71
Dividend payout
Common stock repurchases	-4.88	-0.17		0.00	0.00		0.10				-0.06
Net Debt Issuance	119.82	50.35	0.15	0.61	9.13	0.05	1.22	-0.23	134.56	43.13	0.11	-0.05	25.00	19.71

Change in cash	87.29	38.67	-9.77	-13.17	-7.45	-13.48	-11.41	-12.27	123.35	31.26	-7.76	-6.74	17.46	13.63

Cash Flow - Alto Neuroscience, Inc. (ANRO)